Home

Vaccines, government contracting and cool science

DynPort Vaccine Company manages product development programs for government agencies, and provides consulting, technical and program management services to companies in the biotechnology and pharmaceutical industries. We are developing vaccines and therapeutics to protect against emerging infectious diseases including biological warfare threat agents and seasonal and pandemic influenza.

Our Tumblr site posts news, events and other items related to biopharmaceutical product development (and things we think are just cool). We also offer a free newsletter six times per year, if you prefer news in larger doses.

A team of researchers at the Hebrew University of Jerusalem says it has found a way to block a group of fatal bacterial toxins that have to date resisted all attempts to arrest them through the use of conventional drugs.
These toxins, called superantigens, are produced by a group of “violent” staphylococcal and streptococcal bacteria. When these bacteria attack humans, they set off an extreme immune reaction described as an “immune storm,” that is, an immune response of a magnitude higher in intensity than during a regular immune reaction. The result is often fatal toxic or septic shock brought on by the excessive immune response.

A team of researchers at the Hebrew University of Jerusalem says it has found a way to block a group of fatal bacterial toxins that have to date resisted all attempts to arrest them through the use of conventional drugs.

These toxins, called superantigens, are produced by a group of “violent” staphylococcal and streptococcal bacteria. When these bacteria attack humans, they set off an extreme immune reaction described as an “immune storm,” that is, an immune response of a magnitude higher in intensity than during a regular immune reaction. The result is often fatal toxic or septic shock brought on by the excessive immune response.

nickthejam likes this
dynport posted this